Omalizumab. Molecular model of the drug omalizumab. This monoclonal antibody, sold under the brand name Xolair, binds to free human immunoglobulin E (IgE). It is used to treat moderate to severe persistent asthma in patients who have a positive test to a perennial aeroallergen. The image shows heavy chains (blue, red) and light chains (green, yellow).